BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28652252)

  • 1. Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.
    Marchan R; Büttner B; Lambert J; Edlund K; Glaeser I; Blaszkewicz M; Leonhardt G; Marienhoff L; Kaszta D; Anft M; Watzl C; Madjar K; Grinberg M; Rempel E; Hergenröder R; Selinski S; Rahnenführer J; Lesjak MS; Stewart JD; Cadenas C; Hengstler JG
    Cancer Res; 2017 Sep; 77(17):4589-4601. PubMed ID: 28652252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
    Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
    Granata A; Nicoletti R; Perego P; Iorio E; Krishnamachary B; Benigni F; Ricci A; Podo F; Bhujwalla ZM; Canevari S; Bagnoli M; Mezzanzanica D
    Oncotarget; 2015 May; 6(13):11216-30. PubMed ID: 25796169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.
    Lesjak MS; Marchan R; Stewart JD; Rempel E; Rahnenführer J; Hengstler JG
    Cell Adh Migr; 2014; 8(5):499-508. PubMed ID: 25482527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Glycerol-3-Phosphate Acyltransferase-Dependent Phospholipid Synthesis Modulates Phospholipid Mass and IL-2 Production in Jurkat T Cells.
    Faris R; Weber MM; Seeger DR; Cavazos D; de Graffenried L; Murphy EJ; Jolly CA
    Lipids; 2016 Mar; 51(3):291-301. PubMed ID: 26797755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S; Morishige K; Sawada K; Hashimoto K; Mabuchi S; Kawase C; Ooyagi C; Sakata M; Kimura T
    Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
    Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
    Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
    Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
    Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling.
    Brockmöller SF; Bucher E; Müller BM; Budczies J; Hilvo M; Griffin JL; Orešič M; Kallioniemi O; Iljin K; Loibl S; Darb-Esfahani S; Sinn BV; Klauschen F; Prinzler J; Bangemann N; Ismaeel F; Fiehn O; Dietel M; Denkert C
    J Proteome Res; 2012 Feb; 11(2):850-60. PubMed ID: 22070544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma.
    Song WJ; Dong Y; Luo C; Chen YY
    Pathol Res Pract; 2017 Oct; 213(10):1282-1288. PubMed ID: 28916425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic structure and an alternative transcript of bovine mitochondrial glycerol-3-phosphate acyltransferase gene (GPAM).
    Roy R; Ordovas L; Taourit S; Zaragoza P; Eggen A; Rodellar C
    Cytogenet Genome Res; 2006; 112(1-2):82-9. PubMed ID: 16276094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lipid metabolism related gene GPAM: Molecular characterization, function identification, and association analysis with fat deposition traits.
    Yu H; Zhao Z; Yu X; Li J; Lu C; Yang R
    Gene; 2017 Apr; 609():9-18. PubMed ID: 28131819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YWHAZ promotes ovarian cancer metastasis by modulating glycolysis.
    Shi J; Ye J; Fei H; Jiang SH; Wu ZY; Chen YP; Zhang LW; Yang XM
    Oncol Rep; 2019 Feb; 41(2):1101-1112. PubMed ID: 30535456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
    Ha JH; Yan M; Gomathinayagam R; Jayaraman M; Husain S; Liu J; Mukherjee P; Reddy EP; Song YS; Dhanasekaran DN
    Oncotarget; 2016 Nov; 7(45):72845-72859. PubMed ID: 27655714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.
    Sood AK; Coffin JE; Schneider GB; Fletcher MS; DeYoung BR; Gruman LM; Gershenson DM; Schaller MD; Hendrix MJ
    Am J Pathol; 2004 Oct; 165(4):1087-95. PubMed ID: 15466376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
    Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
    Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.